|   
  
    | Variant #0000167025 (NC_000001.10:g.171076952C>T, NM_001002294.2:c.458C>T (FMO3))
        
          | Chromosome | 1 |  
          | Allele | Unknown |  
          | Affects function (as reported) | Affects function |  
          | Affects function (by curator) | Affects function |  
          | Classification method | - |  
          | Clinical classification | NA |  
          | DNA change (genomic) (Relative to hg19 / GRCh37) | g.171076952C>T |  
          | DNA change (hg38) | g.171107811C>T |  
          | Published as | - |  
          | ISCN | - |  
          | DB-ID | FMO3_000001 See all 6 reported entries |  
          | Variant remarks | variant expected to influence metabolism of drug (xenobiotic) substrates of FMO3 that undergo N- or S-oxygenation; impaired benzydamine N-oxygenation in compound het with E305X or with S173R |  
          | Reference | PubMed:  Mayatepek 2004 |  
          | ClinVar ID | - |  
          | dbSNP ID | rs72549326 |  
          | Origin | In vitro (cloned) |  
          | Segregation | - |  
          | Frequency | - |  
          | Re-site | - |  
          | VIP | - |  
          | Methylation | - |  
          | Average frequency (gnomAD v.2.1.1) | 0.00102 View details |  
          | Owner | Ornicha Prapapan |  
          | Database submission license | No license selected |  
          | Created by | Ornicha Prapapan |  
          | Date created | 2013-02-11 19:15:22 +01:00 (CET) |  
          | Date last edited | 2020-06-05 15:14:37 +02:00 (CEST) |   
 
 
 
       
 
 Variant on transcripts
 |  
 
    Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
    Use our APIs  to retrieve data.
 |